Heron Therapeutics, Inc.
HRTX
$0.84
-$0.03-3.04%
NASDAQ
| 12/31/2025 | 09/30/2025 | 06/30/2025 | 03/31/2025 | 12/31/2024 | |
|---|---|---|---|---|---|
| Net Income | -2.95M | -17.50M | -2.38M | 2.64M | 3.66M |
| Total Depreciation and Amortization | 537.00K | 615.00K | 611.00K | 551.00K | 581.00K |
| Total Amortization of Deferred Charges | 204.00K | 196.00K | 206.00K | 211.00K | 300.00K |
| Total Other Non-Cash Items | 2.10M | 14.38M | 2.69M | 2.20M | 2.02M |
| Change in Net Operating Assets | -9.07M | 3.64M | -11.99M | -14.46M | -18.34M |
| Cash from Operations | -9.18M | 1.33M | -10.87M | -8.87M | -11.78M |
| Capital Expenditure | 0.00 | 0.00 | -208.00K | -109.00K | -638.00K |
| Sale of Property, Plant, and Equipment | 16.00K | 29.00K | 11.00K | 42.00K | 27.00K |
| Cash Acquisitions | -- | -- | -- | -- | -- |
| Divestitures | -- | -- | -- | -- | -- |
| Other Investing Activities | -5.47M | 11.83M | 7.53M | 2.34M | 12.03M |
| Cash from Investing | -5.46M | 11.86M | 7.33M | 2.27M | 11.42M |
| Total Debt Issued | -4.79M | 142.04M | -- | -- | -- |
| Total Debt Repaid | 0.00 | -150.00M | -- | -- | -- |
| Issuance of Common Stock | -- | 20.05M | 587.00K | -- | 423.00K |
| Repurchase of Common Stock | -1.31M | -- | -- | -- | -- |
| Issuance of Preferred Stock | 0.00 | 7.86M | -- | -- | -- |
| Repurchase of Preferred Stock | -- | -- | -- | -- | -- |
| Total Dividends Paid | -- | -- | -- | -- | -- |
| Other Financing Activities | 6.32M | -6.58M | 194.00K | 64.00K | -- |
| Cash from Financing | 219.00K | 13.36M | 781.00K | 64.00K | 423.00K |
| Foreign Exchange rate Adjustments | -- | -- | -- | -- | -- |
| Miscellaneous Cash Flow Adjustments | -- | -- | -- | -- | -- |
| Net Change in Cash | -14.42M | 26.55M | -2.75M | -6.53M | 61.00K |